Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick C Hermann

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Cell Transplantation|March 21, 2008
Concentration of bone marrow total nucleated cells by a point-of-care device provides a high yield and preserves their functional activityPatrick C Hermann, Stephan L Huber, Tanja Herrler, et al.
Cell Transplantation|September 5, 2017
Concentration of Bone Marrow Total Nucleated Cells by a Point-of-Care Device Provides a High Yield and Preserves Their Functional ActivityPatrick C Hermann, Stephan L Huber, Tanja Herrler, et al.
Cancers|September 28, 2021
Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC MiceMiltiadis Tsesmelis, Kanishka Tiwary, Katja Steiger, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 27, 2011
Vascular incorporation of endothelial colony-forming cells is essential for functional recovery of murine ischemic tissue following cell therapyTheresa M Schwarz, Simon F Leicht, Tamara Radic, et al.
Plos One|July 5, 2013
Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Tissue XenograftsPatrick C Hermann, Sara M Trabulo, Bruno Sainz, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 7, 2010
Combination of injectable multiple growth factor-releasing scaffolds and cell therapy as an advanced modality to enhance tissue neovascularizationJaimy Saif, Theresa M Schwarz, David Y S Chau, et al.
Gastroenterology|June 26, 2016
Detection of Hot-Spot Mutations in Circulating Cell-Free DNA From Patients With Intraductal Papillary Mucinous Neoplasms of the PancreasAndreas W Berger, Daniel Schwerdel, Ivan G Costa, et al.
International Journal of Cancer|September 15, 2020
Nintedanib plus mFOLFOX6 as second-line treatment of metastatic, chemorefractory colorectal cancer: The randomised, placebo-controlled, phase II TRICC-C study (AIO-KRK-0111)Thomas J Ettrich, Lukas Perkhofer, Thomas Decker, et al.
Stem Cells International|July 9, 2019
MEK Inhibition Targets Cancer Stem Cells and Impedes Migration of Pancreatic Cancer Cells <i>In Vitro</i> and <i>In Vivo</i>Karolin Walter, Kanishka Tiwary, Marija Trajkovic-Arsic, et al.
Stem Cells (Dayton, Ohio)|February 11, 2011
Inhibition of ataxia telangiectasia- and Rad3-related function abrogates the in vitro and in vivo tumorigenicity of human colon cancer cells through depletion of the CD133(+) tumor-initiating cell fractionEike Gallmeier, Patrick C Hermann, Maria-Theresa Mueller, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Cell Transplantation|March 21, 2008
Concentration of bone marrow total nucleated cells by a point-of-care device provides a high yield and preserves their functional activityPatrick C Hermann, Stephan L Huber, Tanja Herrler, et al.
Cell Transplantation|September 5, 2017
Concentration of Bone Marrow Total Nucleated Cells by a Point-of-Care Device Provides a High Yield and Preserves Their Functional ActivityPatrick C Hermann, Stephan L Huber, Tanja Herrler, et al.
Cancers|September 28, 2021
Deletion of NEMO Inhibits EMT and Reduces Metastasis in KPC MiceMiltiadis Tsesmelis, Kanishka Tiwary, Katja Steiger, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 27, 2011
Vascular incorporation of endothelial colony-forming cells is essential for functional recovery of murine ischemic tissue following cell therapyTheresa M Schwarz, Simon F Leicht, Tamara Radic, et al.
Plos One|July 5, 2013
Multimodal Treatment Eliminates Cancer Stem Cells and Leads to Long-Term Survival in Primary Human Pancreatic Cancer Tissue XenograftsPatrick C Hermann, Sara M Trabulo, Bruno Sainz, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 7, 2010
Combination of injectable multiple growth factor-releasing scaffolds and cell therapy as an advanced modality to enhance tissue neovascularizationJaimy Saif, Theresa M Schwarz, David Y S Chau, et al.
Gastroenterology|June 26, 2016
Detection of Hot-Spot Mutations in Circulating Cell-Free DNA From Patients With Intraductal Papillary Mucinous Neoplasms of the PancreasAndreas W Berger, Daniel Schwerdel, Ivan G Costa, et al.
International Journal of Cancer|September 15, 2020
Nintedanib plus mFOLFOX6 as second-line treatment of metastatic, chemorefractory colorectal cancer: The randomised, placebo-controlled, phase II TRICC-C study (AIO-KRK-0111)Thomas J Ettrich, Lukas Perkhofer, Thomas Decker, et al.
Stem Cells International|July 9, 2019
MEK Inhibition Targets Cancer Stem Cells and Impedes Migration of Pancreatic Cancer Cells <i>In Vitro</i> and <i>In Vivo</i>Karolin Walter, Kanishka Tiwary, Marija Trajkovic-Arsic, et al.
Stem Cells (Dayton, Ohio)|February 11, 2011
Inhibition of ataxia telangiectasia- and Rad3-related function abrogates the in vitro and in vivo tumorigenicity of human colon cancer cells through depletion of the CD133(+) tumor-initiating cell fractionEike Gallmeier, Patrick C Hermann, Maria-Theresa Mueller, et al.
Pageof 5